GPT Healthcare Ltd.
•Add ratio to table
ABOUT
AI Sector View
AI GENERATEDHealthcare
This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.
PROS
- Company has a good return on equity (ROE) track record: 3 Years ROE 23.3%
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 2.04x)
- Working capital cycle has improved - days down from 40 to 19
- Company generates healthy free cash flow
- Attractively priced for its growth - PEG of 0.8
CONS
- Equity base is being diluted - shares outstanding up 345.4%
- Dividend payout exceeds earnings (134.1%) - may be unsustainable
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | 8850.00 | 60.90 | 127249.42 | 0.23 | 610.40 | 38.41 | 7043.50 | 20.56 | 21.73 | 15.70 |
| MAXHEALTH | 1037.20 | 69.29 | 100951.74 | 0.19 | 322.96 | 4.87 | 2366.17 | 16.70 | 14.97 | 25.29 |
| MANIPALHOS | 716.15 | 105.57 | 94200.74 | 0.00 | 2434.30 | — | 30906.30 | — | 13.93 | 23.83 |
| FORTIS | 887.30 | 63.93 | 66987.44 | 0.11 | 272.80 | 2.26 | 2545.03 | 17.46 | 14.07 | 21.28 |
| ASTERDM | 762.95 | 208.69 | 66504.25 | 0.39 | 29.28 | -68.70 | 1310.68 | 21.60 | 11.26 | 19.53 |
| MEDANTA | 1447.55 | 69.98 | 38920.53 | 0.03 | 157.25 | -1.09 | 1304.05 | 26.50 | 19.38 | 21.99 |
| NH | 1867.35 | 46.76 | 38161.31 | 0.24 | 207.27 | 5.37 | 2683.63 | 78.05 | 16.20 | 17.43 |
| KIMS | 768.85 | 158.06 | 32292.20 | 0.00 | 37.40 | -56.00 | 1179.50 | 35.33 | 11.51 | 19.03 |
| LALPATHLAB | 1909.40 | 59.14 | 32049.05 | 1.07 | 1705.00 | 1172.39 | 7977.00 | 1090.95 | 29.56 | 31.03 |
| AGARWALEYE | 507.00 | 108.33 | 16073.23 | 0.00 | 55.02 | 44.56 | 614.02 | 25.97 | 16.14 | 27.75 |
| VIJAYA | 1502.30 | 82.53 | 15473.35 | 0.13 | 53.10 | 37.61 | 230.98 | 22.83 | 30.28 | 42.66 |
| GPTHEALTH | 159.20 | 31.33 | 1306.31 | 1.57 | 12.73 | 65.77 | 126.20 | 17.83 | 23.06 | 19.16 |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
No quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|
| 172 | 212 | 243 | 337 | |
| 135 | 176 | 194 | 264 | |
| Operating Profit | 37 | 36 | 49 | 74 |
| OPM % | 21.42% | 16.90% | 20.18% | 21.88% |
| 3 | 4 | 6 | 5 | |
| Interest | 10 | 14 | 14 | 11 |
| Depreciation | 9 | 11 | 12 | 14 |
| Profit before Tax | 20 | 15 | 29 | 54 |
| Tax % | 26.63% | 26.17% | 26.97% | 22.96% |
| Net Profit | 15 | 11 | 21 | 42 |
| EPS | 0.00 | 0.00 | 2.64 | 5.21 |
| Dividend Payout % | 0.00% | 24.57% | 63.72% | 134.14% |
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 25%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 41%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- 4%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 23%
- Last Year:
- 33%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|
| 18 | 18 | 18 | 80 | |
| 58 | 69 | 76 | 78 | |
| 104 | 130 | 138 | 113 | |
| Trade Payables | 24 | 33 | 26 | 29 |
| 45 | 54 | 53 | 19 | |
| Total Liabilities | 249 | 305 | 311 | 320 |
| 158 | 226 | 220 | 220 | |
| Capital Work in Progress | 32 | 2 | 0 | 1 |
| 1 | 1 | 1 | 10 | |
| 5 | 6 | 6 | 7 | |
| 0 | 0 | 0 | 0 | |
| Cash & Bank | 1 | 1 | 5 | 9 |
| 52 | 69 | 79 | 72 | |
| Total Assets | 249 | 305 | 311 | 320 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|
| 35 | 42 | 40 | 79 | |
| Cash from Investing | -31 | -54 | -16 | -5 |
| Cash from Financing | -0 | 12 | -22 | -57 |
| 1 | -1 | 4 | 3 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
2026-08-07 - GPT Healthcare Limited has informed the Exchange about Transcript
2026-08-07 - GPT Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 06, 2026. Further, the company has informed the Exchange regarding voting results.
2026-08-06 - GPT Healthcare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 06, 2026
2026-08-04 - GPT Healthcare Limited has informed the Exchange about Link of Recording
2026-08-04 - GPT Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
2026-08-03 - Press Release on UFR for Q1FY2027
2026-08-03 - GPT Healthcare Limited has informed the Exchange about Investor Presentation
2026-08-03 - GPT Healthcare Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-07-25 - GPT Healthcare Limited has informed the Exchange about Schedule of meet
News
Recent coverage and analyst commentary for GPTHEALTH
Loading news…
AI Stock Analyst
GPT Healthcare Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account